Short- and mid-term repeatability of macular pigment optical density measurements using spectral fundus reflectance
- PMID: 22362012
- DOI: 10.1007/s00417-012-1946-3
Short- and mid-term repeatability of macular pigment optical density measurements using spectral fundus reflectance
Abstract
Background: Several methods have been proposed for measuring macular pigment optical density (MPOD). To date, none of the realized techniques can be considered as "gold standard". A key issue for the clinical applicability of a method is its repeatability. In this study, we investigated short- and mid-term repeatability of MPOD measurements using reflectometry.
Methods: A total of 12 healthy young subjects were measured 5 times on 5 consecutive days. Repeatability over 6 months was investigated in patients with AMD. The data in AMD patients were taken from a recently published placebo controlled study investigating the effect of lutein supplementation on MPOD (n = 37; [1]). Four measurements over 6 months were used to calculate repeatability. Spectral fundus reflectance of the fovea was measured in a 2.3° detection field with a custom-built fundus reflectometer. Calculation of MPOD was based on a previously published fundus reflectance model.
Results: The coefficients of variation were 6.2 ± 2.4% and 8.0 ± 5.5% in the healthy and AMD group, respectively. Bland-Altman plots indicate that the difference between measurements at day 1 and day 5 in healthy subjects and day 1 and month 6 in AMD patients was small. The maximum deviation in MPOD in a healthy subject was 0.07 (22.6%), and 0.17 (51.5%) in a patient with AMD.
Conclusions: Reflectometry provides adequate short-term and mid-term repeatability for measuring MPOD. Accordingly, the technique makes it possible to monitor MPOD in patients with AMD and to study the influence of supplementation in these subjects. In addition, the variability of the technique is small enough to allow for clinical trials with reasonable sample size.
Similar articles
-
Comparison of macular pigment in patients with age-related macular degeneration and healthy control subjects - a study using spectral fundus reflectance.Acta Ophthalmol. 2012 Aug;90(5):e399-403. doi: 10.1111/j.1755-3768.2012.02423.x. Acta Ophthalmol. 2012. PMID: 23035764
-
Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods.Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1565-74. doi: 10.1007/s00417-006-0289-3. Graefes Arch Clin Exp Ophthalmol. 2006. PMID: 16642363
-
LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.Optometry. 2007 May;78(5):213-9. doi: 10.1016/j.optm.2006.10.019. Optometry. 2007. PMID: 17478338 Clinical Trial.
-
Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.Nutrients. 2016 Jul 12;8(7):426. doi: 10.3390/nu8070426. Nutrients. 2016. PMID: 27420092 Free PMC article. Review.
-
Macular pigment and healthy vision.Optometry. 2009 Oct;80(10):592-8. doi: 10.1016/j.optm.2009.08.002. Optometry. 2009. PMID: 20576249 Review.
Cited by
-
Bayer Filter Snapshot Hyperspectral Fundus Camera for Human Retinal Imaging.Curr Eye Res. 2017 Apr;42(4):629-635. doi: 10.1080/02713683.2016.1221976. Epub 2016 Oct 21. Curr Eye Res. 2017. PMID: 27767345 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical